Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Specific treatment response signature significantly diminishes at 2 weeks onwards.

Domaine:

healthcare
Créateur:
ChlChrMatKat
Hôte:avatar

A specific TB treatment response signature was derived from significantly differentially expressed genes between untreated samples in the South Africa Active TB Training Set and their corresponding 6 month samples, 320 transcripts. (A) Heatmap of South Africa 2011 Active TB Training Set, normalised to the median of all transcripts, shows transcripts differentiating over time in response to treatment. (B) Temporal molecular response further shows significant and early changes in response to TB treatment in the Active TB Training Set (linear mixed models, bars represent mean & 95% confidence intervals, *** = p<0.001, ** = p<0.01, * = p<0.05). (C) Heatmap of South Africa 2011 Active TB Test Set, normalised to the median of all transcripts, shows transcripts differentiating over time in response to treatment. (D) Temporal molecular response also shows in the Active TB Test Set significant and early changes in response to TB treatment. (E) IPA of the 320 transcripts showing the most significant pathways. (F) Venn diagram shows many overlapping genes between the active TB 664-transcript signature and the treatment specific 320-signature.

Visit

figshare.com

Tags

Cell BiologyMolecular BiologyBiological SciencesInfectious Diseasesdiminishesweeks

Licenses

CC BY 4.0

Similaires

mjc2244/Uganda-Sepsis-Response-Signature-AnalysesA Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent TuberculosisSpatial and Temporal Trends of SARS-CoV-2 RNA from Wastewater Treatment Plants over 6 Weeks in Cape Town, South AfricaZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin responseTuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection StatusEffect of Environmental Factors on Tuberculosis Patients Treatment Response at Lower Rift Valley, Southern Ethiopia

mjc2244/Uganda-Sepsis-Response-Signature-Analyses

R code for Uganda Sepsis Response Signature Analyses

A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis

South Africa has the highest prevalence of HIV and tuberculosis (TB) co-infection globally. Recurren

Spatial and Temporal Trends of SARS-CoV-2 RNA from Wastewater Treatment Plants over 6 Weeks in Cape Town, South Africa

Recent scientific trends have revealed that the collection and analysis of data on the occurrence an

ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response

Abstract: Genome analysis of diverse human populations has contributed to the identification of nove

Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status

HIV infection causes systemic immune activation, impacts TB disease progression and hence may influe

Effect of Environmental Factors on Tuberculosis Patients Treatment Response at Lower Rift Valley, Southern Ethiopia